文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

美国161家医院四个电子健康记录数据库中动脉血气检测的种族与性别差异

Differences in Arterial Blood Gas Testing by Race and Sex across 161 U.S. Hospitals in Four Electronic Health Record Databases.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01
一句话结论在重症患者中,亚洲、黑人及女性患者接受动脉血气检测更少且更延迟,可能加剧隐匿性低氧血症。

该研究分析2001至2019年美国161家医院四个电子健康记录数据库中的184,178例ICU入住记录,评估动脉血气检测的种族与性别差异。校正序贯器官衰竭评估评分、医院和年龄等混杂因素后,与白人患者相比,亚洲、黑人和西班牙裔或拉丁裔患者接受动脉血气检测的比值比分别为0.807、0.859和0.919,首次检测延迟的风险比分别为0.855和0.833(黑人),重复检测发生率比分别为0.913和0.913。女性患者接受检测的比值比为0.926,首次检测风险比为0.958,重复检测发生率比为0.951。在机械通气和留置动脉导管的患者中,这些差异仍然一致。作者认为,在肤色校正脉搏血氧仪可用之前,公平的动脉血气检测是减轻隐匿性低氧血症的最佳策略。

要点

  • 与白人患者相比,亚洲、黑人和西班牙裔或拉丁裔ICU患者接受动脉血气检测的比值比分别为0.807、0.859和0.919。
  • 亚洲和黑人患者首次动脉血气检测延迟的风险比分别为0.855和0.833(P<0.001)。
  • 亚洲和黑人患者重复动脉血气检测的发生率比均为0.913。
  • 女性患者接受动脉血气检测的比值比为0.926,首次检测风险比为0.958,重复检测发生率比为0.951。
  • 在机械通气和留置动脉导管的患者中,上述检测差异仍然一致。

适用人群与场景

  • 2001至2019年美国161家医院的ICU入住患者,共184,178例ICU入住记录。
  • 亚组分析聚焦于机械通气患者和留置动脉导管的患者。

研究设计与关键结果

  • 研究类型为多中心回顾性队列分析,数据来自Duke、MIMIC-III、MIMIC-IV和eICU协作研究数据库,共184,178例ICU入住记录(35.0%有动脉血气检测结果;1.9%亚洲人,16.5%黑人,3.5%西班牙裔或拉丁裔,78.1%白人,45.7%女性)。
  • 与白人患者相比,亚洲、黑人和西班牙裔或拉丁裔患者接受动脉血气检测的比值比分别为0.807(95%CI 0.741–0.879)、0.859(95%CI 0.830–0.888)、0.919(95%CI 0.865–0.976)。
  • 亚洲和黑人患者首次动脉血气检测延迟的风险比分别为0.855(95%CI 0.803–0.911)和0.833(95%CI 0.814–0.853),P<0.001。
  • 亚洲和黑人患者重复动脉血气检测的发生率比均为0.913(亚洲95%CI 0.845–0.986;黑人95%CI 0.887–0.940)。
  • 与男性患者相比,女性患者接受动脉血气检测的比值比为0.926(95%CI 0.905–0.948),首次检测风险比为0.958(95%CI 0.942–0.974),重复检测发生率比为0.951(95%CI 0.931–0.971)。
  • 在机械通气和留置动脉导管的患者中,上述差异一致。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在肤色校正脉搏血氧仪可用之前,公平的动脉血气检测是减轻隐匿性低氧血症的最佳策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Pulse oximetry accuracy varies across races, underscoring the importance of routine arterial blood gas (ABG) testing, the gold standard for assessing oxygen saturation. Objectives: This study aimed to assess disparities in ABG testing among critically ill patients by race and sex. Methods: Records from 2001 to 2019 in 161 U.S. hospitals were analyzed, including Duke, MIMIC-III (Medical Information Mart for Intensive Care), MIMIC-IV, and the eICU Collaborative Research Database. The study evaluated ABG test incidence; time to first test; and frequency of subsequent tests, adjusting for confounders, including the Sequential Organ Failure Assessment, hospital, and age. Subgroup analyses focused on patients with arterial lines and mechanical ventilation. Measurements and Main Results: The cohort included 184,178 ICU admissions (35.0% with ABG test results; 1.9% Asian, 16.5% Black, 3.5% Hispanic or Latino, 78.1% White, 45.7% female). Compared with White patients, Asian, Black, and Hispanic or Latino patients were less likely to have an ABG test (odds ratio [OR] [95% confidence interval (CI)], 0.807 [0.741, 0.879]; 0.859 [0.830, 0.888]; 0.919 [0.865, 0.976], respectively), experienced delays to initial ABG testing (hazard ratio [HR] [95% CI], Asian, 0.855 [0.803, 0.911]; Black, 0.833 [0.814, 0.853]; P < 0.001), and were less likely to have repeated ABG tests (incidence rate ratio [95% CI], Asian 0.913 [0.845, 0.986]; Black 0.913 [0.887, 0.940]). Compared with male patients, female patients underwent fewer ABG tests (OR [95% CI], 0.926 [0.905, 0.948]), had delays in initial testing (HR [95% CI], 0.958 [0.942, 0.974]), and had fewer repeated ABG tests (incidence rate ratio [95% CI], 0.951 (0.931, 0.971)). These findings were consistent among patients who were mechanically ventilated and had arterial lines placed. Conclusions: Asian, Black, and female patients had significantly reduced and delayed rates of ABG testing. Inequitable ABG testing may exacerbate the prevalence of hidden hypoxemia. Until skin tone-corrected pulse oximeters are available, equitable ABG testing remains the best strategy to mitigate hidden hypoxemia.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Matos J, Alwakeel M, Hao S, et al. Differences in Arterial Blood Gas Testing by Race and Sex across 161 U.S. Hospitals in Four Electronic Health Record Databases. Am J Respir Crit Care Med. 2025. PMID: 40126408. doi:10.1164/rccm.202406-1242OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。